NUVA - ニュ―ベイシブ （NuVasive Inc.） ニュ―ベイシブNUVAのチャート
NUVAの企業情報
| symbol | NUVA |
|---|---|
| 会社名 | Nuvasive Inc （ニュ―ベイシブ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ニュベーシブ（NuVasive Inc）は医療機器会社である。同社は、最小限の破壊的外科用製品の開発と、背骨手術のための手続き型統合ソリューションの開発に集中する。同社の製品ポートフォリオは、脊椎固定術を補助するために使用される生物製剤を含む脊椎固定手術のアプリケーションに重点を置く。主力製品には、最大アクセス外科手術（MAS）と呼ばれる最小限の破壊的手術プラットフォームが含まれる。このプラットフォームには、NVM5を含むソフトウェア駆動の神経検出および回避システム、術中モニタリングサービスおよびサポート、統合スプリットブレードレトラクタシステムであるMaXcess、及び各種インプラント、バイオロジックが含まれる。このプラットフォームは、MaXcessリトラクタ、特殊インプラントおよび固定製品、外科医が神経を検出してナビゲートすることを総合的に可能にするインプラント送達のためのスパインへのカスタマイズされたアクセスを指示する3つの製品カテゴリを組み合わせている。 ニュ―ベイシブは米国の医療機器メ―カ―。整形外科領域の脊椎外科向けインプラント、神経モニタ―リング機器などの開発、製造、リ―ス、修理、設置・取り付け、調査研究、販売を行う。米国以外の拠点はプエルトリコ、英国、ドイツ、オ―ストラリア、シンガポ―ル、日本など。本社はカリフォルニア州。 nuvasive® is a place where we create new and innovative products at a speed that drives our ability to deliver absolute responsiveness®, and gives us a competitive edge. at nuvasive, we empower our shareowners to influence results and significantly contribute to the success of the company. together we make nuvasive a leader in the spine industry with our unique focus on speed of innovation®. every member of the nuvasive family has the opportunity to improve the lives of patients through their work. these life-changing career paths show how hard work, a competitive spirit and your unwavering dedication to the patient can take you and your career to new places. in addition to being a great place to have a career, we’re also committed to giving back and supporting our communities. through an attitude of gratitude, nuvasive provides life-changing spinal surgery to disadvantaged communities through our nonprofit, the nuvasive spine foundation®, and offers patient-to-patient support through |
| 本社所在地 | 7475 Lusk Boulevard San Diego CA 92121 USA |
| 代表者氏名 | Gregory T. Lucier グレゴリー・T・ルシエ |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 858-909-1800 |
| 設立年月日 | 35612 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2004年 |
| 従業員数 | 2600人 |
| url | www.nuvasive.com |
| nasdaq_url | https://www.nasdaq.com/symbol/nuva |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 238.77000 |
| 終値（lastsale） | 69.67 |
| 時価総額（marketcap） | 3582601952.16 |
| 時価総額 | 時価総額（百万ドル） 3190.763 |
| 売上高 | 売上高（百万ドル） 161.169 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3750.266 |
| 当期純利益 | 当期純利益（百万ドル） 22.43600 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 NuVasive Inc. revenues increased 7% to $542.1M. Net loss totaled $15.6M vs. income of $24.6M. Revenues reflect International (excludes Puerto Rico) segment increase of 29% to $101.8M United States segment increase of 3% to $440.3M. Net loss reflects Litigation liability (gain) loss increase from $0K to $27.8M (expense) Sales Marketing increase of 7% to $283M (expense). |
NUVAのテクニカル分析
NUVAのニュース
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript 2023/05/11 02:15:09 Seeking Alpha
NuVasive, Inc. (NASDAQ:NASDAQ:NUVA) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ETCompany ParticipantsJuliet Cunningham - Vice President, Investor RelationsChris Barry - Chief…
Recap: NuVasive Q1 Earnings 2023/05/10 21:10:35 Benzinga
NuVasive (NASDAQ: NUVA ) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings NuVasive beat estimated earnings by 9.3%, reporting an EPS of $0.47 versus an … Full story available on Benzinga.com
NuVasive Non-GAAP EPS of $0.47 beats by $0.05, revenue of $307.7M beats by $9.26M 2023/05/10 20:31:46 Seeking Alpha
NuVasive press release (NUVA): Q1 Non-GAAP EPS of $0.47 beats by $0.05.Revenue of $307.7M (+5.8% Y/Y) beats by $9.26M.The Company continues to expect 2023 net sales growth of 6%ꟷ8%…
NuVasive, Inc. Q1 Earnings Summary 2023/05/10 20:30:00 Finanz Nachrichten
WASHINGTON (dpa-AFX) - Below are the earnings highlights for NuVasive, Inc. (NUVA):Earnings: -$1.01 million in Q1 vs. $19.20 million in the same period last year. EPS: -$0.02 in Q1 vs. $0.35 in th…
NuVasive Announces First Quarter 2023 Financial Results 2023/05/10 20:05:00 PR Newswire
Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc SAN DIEGO, May 10, 2023 /PRNewswire/ -- NuVasive, Inc….
NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results 2023/05/04 11:00:00 PR Newswire
SAN DIEGO, May 4, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its first quarter 2023 results on…
Globus Medical: Still Very Attractive After NuVasive Selloff 2023/05/04 09:41:53 Seeking Alpha
Globus Medical caught the headlines after announcing the NuVasive merger. Check out why I reiterate GMED stock as a long-term buy.
Globus Medical, Nuvasive shareholders approve $3.1B merger deal 2023/04/28 16:31:57 Business Journals
When the merger closes, Globus shareholders will own about 72% of the combined company.
Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive 2023/04/27 23:08:14 Benzinga
AUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive (NASDAQ: NUVA ). As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction. "Globus Medical shareholders showed an overwhelming level of support for this merger," said Dan Scavilla, president and CEO of Globus Medical. "Globus Medical and NuVasive are committed to providing innovative technologies and industry leading clinical support to help surgeons and healthcare providers deliver continually improving care. Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients.
NuVasive merger with Globus Medical approved by shareholders 2023/04/27 21:06:24 Seeking Alpha
NuVasive (NUVA) shareholders have approved the company''s planned merger with Globus Medical (GMED). Read more here.
NuVasive: An Excellent Growth Story In Spine Surgery 2022/12/28 14:17:14 Seeking Alpha
NuVasive''s XLIF and ALIF spine surgery procedures will drive its revenue and profitability growth. Click here to find out why NUVA is a long-term Buy.
Minimally Invasive Surgery Global Market Report 2022: Ukraine-Russia War Impact 2022/12/20 11:27:00 GlobeNewswire
Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical. Major players in the minimally invasive surgery market are Arthrex, B. Braun, Intuitive, Medtronic Inc, OmniGuide Inc , Eximis Surgical Inc, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Inc, NuVasive Inc, Fortimedix Surgical BV, Microline Surgical Inc, Cirtec Medical Corp, Johnson & Johnson Services Inc, Philips Healthcare, TransEnterix , Silex Medical LLC and Freudenberg Medical.
If you Invested $10K in CubeSmart 5 Years Ago, Here''s How Much You Would Be Making In Dividends Today 2022/12/08 15:59:23 Benzinga
One of the best things about investing in high-quality real estate investment trusts ( REITs ) is that the dividends paid over time will likely increase as the company’s business and earnings grow. And as those dividends grow, the yield on your original purchase price will increase. But how does an investor know which REITs are likely to increase dividends in the future? One of the best measures is to look at companies whose dividend has been growing substantially over the previous five years and select one of those rather than a company whose dividend has remained flat or only increased slightly over time. One such company with a terrific dividend track record since 2017 is CubeSmart (NYSE: CUBE ), a Malvern, Pennsylvania-based self-storage REIT with over 1,300 storage facilities in 39 states across the U.S. CubeSmart’s 52-week price range is $36.82 to $57.34. The most recent closing price was $42.35. CubeSmart shares bolted higher this week after it was announced that it will be included in the S&P MidCap 400 Index, replacing NuVasive Inc. , which moved to the S&P …
Allegro Microsystems and CubeSmart Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 2022/12/02 22:15:00 S&P Global Platts
NEW YORK, December 2, 2022: S&P Dow Jones Indices (“S&P DJI”) will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 19 to coincide with the quarterly rebalance: • Allegro Microsystems Inc. (NASD:ALGM) and CubeSmart (NYSE:CUBE) will replace Semtech Corp. (NASD: SMTC) and NuVasive Inc. (NASD: NUVA) respectively in the S&P MidCap 400. Semtech and NuVasive will replace Diversified Healthcare Trust (NASD:DHC) and Tupperware Brands Corp. (NYSE:TUP) respectively in the S&P SmallCap 600.
NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference 2022/11/16 12:00:00 PR Newswire
SAN DIEGO, Nov. 16, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate…